CRSP
Price
$47.78
Change
-$0.90 (-1.85%)
Updated
Dec 11, 04:59 PM (EDT)
68 days until earnings call
PMVP
Price
$1.58
Change
-$0.02 (-1.25%)
Updated
Dec 11, 04:59 PM (EDT)
77 days until earnings call
Ad is loading...

CRSP vs PMVP

Header iconCRSP vs PMVP Comparison
Open Charts CRSP vs PMVPBanner chart's image
CRISPR Therapeutics AG
Price$47.78
Change-$0.90 (-1.85%)
Volume$20.27K
CapitalizationN/A
PMV Pharmaceuticals
Price$1.58
Change-$0.02 (-1.25%)
Volume$600
CapitalizationN/A
CRSP vs PMVP Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. PMVP commentary
Dec 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and PMVP is a StrongSell.

COMPARISON
Comparison
Dec 12, 2024
Stock price -- (CRSP: $47.78 vs. PMVP: $1.57)
Brand notoriety: CRSP and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 96% vs. PMVP: 51%
Market capitalization -- CRSP: $4.23B vs. PMVP: $82.28M
CRSP [@Biotechnology] is valued at $4.23B. PMVP’s [@Biotechnology] market capitalization is $82.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • PMVP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than PMVP.

Price Growth

CRSP (@Biotechnology) experienced а -6.57% price change this week, while PMVP (@Biotechnology) price change was -6.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.49%. For the same industry, the average monthly price growth was -4.71%, and the average quarterly price growth was +10.97%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

PMVP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.23B) has a higher market cap than PMVP($82.3M). CRSP YTD gains are higher at: -23.674 vs. PMVP (-48.387). PMVP has higher annual earnings (EBITDA): -77.72M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. PMVP (183M). PMVP has less debt than CRSP: PMVP (13.3M) vs CRSP (228M). CRSP has higher revenues than PMVP: CRSP (200M) vs PMVP (0).
CRSPPMVPCRSP / PMVP
Capitalization4.23B82.3M5,135%
EBITDA-313.08M-77.72M403%
Gain YTD-23.674-48.38749%
P/E RatioN/AN/A-
Revenue200M0-
Total Cash1.94B183M1,058%
Total Debt228M13.3M1,714%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPPMVP
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 28 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCMPX21.730.27
+1.26%
HCM Dividend Sector Plus Investor
JFACX38.960.42
+1.09%
JHancock Fundamental All Cap Core R2
MIISX7.26N/A
N/A
BNY Mellon Income Stock Inv
EFCNX21.52N/A
N/A
Emerald Insights Investor
AEIYX9.41-0.05
-0.53%
American Century Equity Income Y

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.85%
BEAM - CRSP
73%
Closely correlated
-4.30%
PRME - CRSP
62%
Loosely correlated
-1.86%
NTLA - CRSP
61%
Loosely correlated
-4.21%
EDIT - CRSP
60%
Loosely correlated
-5.24%
RXRX - CRSP
60%
Loosely correlated
+1.47%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+0.63%
MDGL - PMVP
44%
Loosely correlated
-1.78%
SEER - PMVP
42%
Loosely correlated
+3.24%
CLLS - PMVP
39%
Loosely correlated
-1.02%
MGTX - PMVP
37%
Loosely correlated
-3.40%
PDSB - PMVP
35%
Loosely correlated
-2.28%
More